WuXi AppTec News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.11.23	WuXi AppTec Named 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year by Frost & Sullivan (PR Newswire)
30.10.23	WuXi AppTec Continued Solid Growth in the First Three Quarters of 2023 on Top of an Exceptionally Strong Year in 2022, with Profit Growth Continuously Exceeding Revenue Growth (PR Newswire)
31.07.23	WuXi AppTec Announced Strong Results of the Second Quarter and First Half of 2023, on Top of an Exceptionally Strong Year in 2022 (PR Newswire)
24.04.23	WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022 (PR Newswire)
20.03.23	WuXi AppTec Reports Record Results in 2022 (PR Newswire)
21.12.22	WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index (PR Newswire)
30.11.22	WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan (PR Newswire)
26.10.22	WuXi AppTec Reports Record Year-to-Date Results in 2022, Third Quarter Revenue over RMB10 Billion (PR Newswire)
26.09.22	WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility (PR Newswire)
09.09.22	WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility to Enhance Global CRDMO Services for Customers (PR Newswire)
16.08.22	WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware (PR Newswire)
12.08.22	WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology (PR Newswire)
26.07.22	WuXi AppTec Reports Record First-Half Results in 2022 (PR Newswire)
07.07.22	WuXi STA Opens New Large-scale Oligonucleotide and Peptide Manufacturing Facility (PR Newswire)
25.04.22	WuXi AppTec Reports Record First-Quarter In 2022 (PR Newswire)
23.03.22	WuXi AppTec Reports Strong Revenue Growth in 2021 (PR Newswire)
08.03.22	WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies (PR Newswire)
16.12.21	Statement by WuXi AppTec Regarding Recent Market Fluctuation (PR Newswire)
09.12.21	WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan (PR Newswire)
29.10.21	WuXi AppTec Reports Strong Third-Quarter 2021 Results (PR Newswire)
06.09.21	WuXi AppTec Receives AA ESG Rating from MSCI (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	28.46	2.63 %	K V
Swiss Life Hldg	712.60	1.86 %	K V
Part Grp Hldg	1’245.50	1.26 %	K V
Zurich Insur Gr	545.00	1.15 %	K V
Swiss Re	132.70	1.14 %	K V
Givaudan	3’945.00	-0.53 %	K V
Geberit	511.20	-0.66 %	K V
Alcon	76.38	-0.68 %	K V
Sika	212.90	-1.34 %	K V
CieFinRichemont	134.25	-2.65 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu WuXi AppTec Co., Ltd. (H) Unsponsored American Depositary Share Repr 1 Sh -H-

Aktien Top/Flop

Meistgelesene Nachrichten